13 results on '"Martin, Ross"'
Search Results
2. SAT-405 Differential expression and sequence variants of sodium taurocholate cotransporting polypeptide (NTCP) do not affect HDV inhibition by Bulevirtide (BLV)
3. SAT-371 No amino acid substitution in HBV PreS1, HDAg, or NTCP associated with suboptimal response to bulevirtide in combination with pegylated interferon alfa-2a treatment in participants with chronic hepatitis delta: results from MYR204 a phase 2b study
4. No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patients
5. HDV full genome sequencing and sensitive HBV genotyping from a large cohort of HBV/HDV co-infected patients
6. Polymorphic analysis of bulevirtide sequence in PreS1 of large HBsAg across HBV genotypes A-H
7. Bulevirtide is broadly active against all HDV genotypes expressing envelopes from HBV genotypes A-H and a large panel of clinical isolates
8. No detectable resistance to bulevirtide in participants with chronic hepatitis D (CHD) through 24 weeks of treatment
9. TOP-103 - HDV full genome sequencing and sensitive HBV genotyping from a large cohort of HBV/HDV co-infected patients
10. Developing a sensitive HBV genotyping assay for HBV DNA suppressed patients using both DNA and RNA sequencing
11. NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome
12. Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir
13. SAT396 - Developing a sensitive HBV genotyping assay for HBV DNA suppressed patients using both DNA and RNA sequencing.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.